[1]
Bernardo, M. et al. 2007. Cost-effectiveness analysis of the prevention of relapse of schizophrenia in the ZEUS longitudinal study Ziprasidone Extended Use in Schizphrenia (ZEUS). Actas Españolas de Psiquiatría. 35, 4 (Jul. 2007), 259–262.